The Sanitary and Epidemiological Committee of Uzbekistan has instructed to withdraw the syrup "Rinotin Kids" from all pharmacies in the country.
In the first quarter of this year, the pharmaceutical company produced 1 trillion 157 billion soums of drugs and medicines in Uzbekistan, Sevara Tolaganova, the head of the information service of the AOKA Agency for the Development of Pharmacy Network, announced at the briefing. During this period, pharmaceutical manufacturers shipped $37 million worth of products abroad and mastered $25 million of investments in 17 projects.
Another batch of Sofosbuvir-400mg anti-hepatitis C drug has been delivered to Tashkent from Egypt.
The sixth batch of the drug Sofosbuvir-400mg against hepatitis C in the amount of 6,720 units was delivered to Tashkent from Egypt.
The fifth batch of the drug Sofosbuvir-400mg against hepatitis C in the amount of 6,720 units was delivered to Tashkent from Egypt.
The fourth batch of the drug Sofosbuvir-400mg against hepatitis C in the amount of 6,720 units was delivered to Tashkent from Egypt.
Another batch of the hepatitis C drug Sofosbuvir-400mg in the amount of 6,720 units was delivered to Tashkent from Egypt.
As part of the implementation of the initiative of the President of Uzbekistan to ensure 100% treatment of patients with hepatitis C in 2024, the supply of medicines from Egypt will continue.
Head of the Department for Cooperation with European Countries and EU Institutions of the Uzbek Foreign Ministry Oybek Shakhavdinov met in Stockholm with a representative of the Swedish company AstraZeneca AB.
On December 7, the World Health Organization published a list of low-quality syrups and suspensions. It includes the medicines Albergo, Madonna, Mucorid, Ulcofin and Zincell, produced by the Pakistani company Pharmix Laboratories (Pvt) Ltd.
